Cosmo to pay Valeant $3 million in breach of contract loss

16-04-2018

Cosmo to pay Valeant $3 million in breach of contract loss

jansucko / iStockphoto.com

Ireland-based Cosmo Pharmaceuticals has lost a legal battle against Valeant Pharmaceuticals, costing it $3 million.


Cosmo Pharmaceuticals, Valeant Pharmaceuticals, licence agreement, International Chamber of Commerce, Alessandro Della Chà

LSIPR